AssetMark Inc’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.3K Buy
1,232
+399
+48% +$9.22K ﹤0.01% 2031
2026
Q1
$19.9K Sell
833
-38
-4% -$929 ﹤0.01% 2055
2025
Q4
$19.7K Buy
871
+117
+16% +$2.55K ﹤0.01% 2012
2025
Q3
$15.2K Buy
754
+490
+186% +$8.21K ﹤0.01% 2002
2025
Q2
$3.77K Buy
264
+111
+73% +$1.3K ﹤0.01% 2223
2025
Q1
$1.61K Sell
153
-42
-22% -$475 ﹤0.01% 2217
2024
Q4
$2.36K Buy
195
+68
+54% +$890 ﹤0.01% 2083
2024
Q3
$1.87K Buy
127
+96
+310% +$1.34K ﹤0.01% 1893
2024
Q2
$447 Sell
31
-2
-6% -$32 ﹤0.01% 1933
2024
Q1
$537 Buy
33
+17
+106% +$266 ﹤0.01% 1721
2023
Q4
$238 Buy
+16
New +$181 ﹤0.01% 1747
2023
Q1
Sell
-18
Closed -$220 1622
2022
Q4
$220 Hold
18
﹤0.01% 1540
2022
Q3
$0 Hold
18
﹤0.01% 1548
2022
Q2
$0 Hold
18
﹤0.01% 1524
2022
Q1
$0 Hold
18
﹤0.01% 1605
2021
Q4
$1K Hold
18
﹤0.01% 1424
2021
Q3
$1K Hold
18
﹤0.01% 1315
2021
Q2
$1K Buy
+18
New +$594 ﹤0.01% 1242

Other funds holding ELAN

AssetMark Inc's ELAN Position: Q2 2026 in Review

AssetMark Inc increased its Elanco Animal Health (ELAN) stake by 48% in Q2 2026, buying an estimated $9.22K and bringing the position to 1,232 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

AssetMark Inc first reported a position in ELAN in Q2 2021 and has held it in 18 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • AssetMark Inc held 1,232 shares of Elanco Animal Health worth $30.3K as of Q2 2026.
  • AssetMark Inc bought 399 Elanco Animal Health shares in Q2 2026, an estimated $9.22K.
  • Elanco Animal Health made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2031 holding.
  • AssetMark Inc first reported a position in Elanco Animal Health in Q2 2021 and has held it in 18 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.